References
- Meyer zum Buschenfelde KH. Immunopathology of chronic liver diseases. Verh Dtsch Ges Pathol 1995; 79: 186–97
- Wejstal R. Immune-mediated liver damage in chronic hepatitis. C Scand J Gastroent 1995; 30: 609–13
- Schlaak F, Lohr H, Gallati H, Meyer zum Buschenfelde K H, Fleischer B. Analysis of in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis. Clin Exp Immunol 1993; 94: 168–73
- Koziel M J, Dudley D, Afdhal N, Grakoui A, Rice C M, Choo Q L, Houghton M, Walker BD. HLA class 1-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 1995; 96: 2311–21
- Lohr H F, Schlaak J F, Kollmannsperger S, Dienes H P, Meyer zum Buschenfelde K H, Gerken G. Liver-infiltrating and circulating CD4+ T cells in chronic hepatitis C: immunodominant epitopes, HLA-restriction and functional significance. Liver 1996; 16: 174–84
- Fukuda K, Nishiguchi S, Kuroki T, Mormoto H, Sakuraj M, Otani S, Matsuhisa H, Kobajashi K. Nonisototic in situ detection of hepatitis C virus in peripheral blood mononuclear cells. J Hepatol 1995; 23: 94, Suppl 1
- Mihm S, Hartmann H, Ramadori G. Detection of antigenomic HCV RNA associated with peripheral blood polymorphonuclear granulocytes in patients with chronic hepatitis. C J Hepatol 1995; 23: 88, Suppl 1
- Moldvay J, Deny P, Pol S, Brechot C, Lamas E. In situ hybridization for the detection of hepatitis C virus RNA in mononuclear cells of peripheral blood from infected patients. Orv Hetil 1995; 136: 2267–71
- Booth J CL, Walters J, Brown J L, Thomas HC. The cellular tropism of HCV. J Hepatol 1995; 23: 104, Suppl 1
- Chang T T, Young K C, Yang Y Y, Lei H J, Wu HL. Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection. Hepatology 1996; 23: 977–81
- Kusaka S, Okusa A, Araki A, Fujiki K, Takashimuzu I, Okayasu I, Jamomoto N, Sato Ch. Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cell. J Med Virology 1995; 46: 265–8
- Taliani G, Badolato M, Lecce R, Poliandri G, Bazzi A, Duca F, Pasquazzi C, Clementi C, Furlan C, De Bac C. Hepatitis C Virus RNA in peripheral blood mononuclear cells: relation with response to interferon treatment. J Med Virology 1995; 47: 16–22
- Osna N, Duk A, Sochnev A. Interferon gamma production in whole peripheral blood culture in acute hepatitis B Scand. J Clin Lab Invest 1996; 56: 145–50
- Quiroga J A, Martin J, Pardo M, Carreno V. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha. Digest Dis Sci 1994; 39: 2485–96
- Jirillo E, Greco B, Caradonna L, Satalino R, Pugliese V, Cozzolongo R, et al. Evaluation of cellular immune response and soluble mediators in patients with chronic hepatitis C (cHCV) infection. Immunopharmacol Immunotoxicol 1995; 17: 347–64
- Lechmann M, Irrgang B, Bar S, Woitas R, Leifeld L, Ihlenfeld H G, et al. Antigen specific CD 30 induction on CD4+ memory T lymphocytes in patients with chronic hepatitis C and healthy anti- HCV seropositives. J Hepatol 1996; 25: 79, Suppl 1
- Lohr H F, Schlaak J H, Gerken G, Fleischer B, Dienes H-P, Meyer zum Buschenfelde KH. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T-lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994; 14: 161–6
- Tsai S-T, Liaw Y-F, Chen M-H, Huang C-Y, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: implication for chronicity. Hepatology 1997; 25: 449–58
- Lechman M, Langhans B, Bar S, Woitas R, Leifeld H G, Ihlenfeldt H G, et al. Deficient secretion of Th1 cytokines in patients with chronic hepatitis. C J Hepatology 1997; 26: 115, Suppl 1
- Gately M K, Magram I, Wu C, Mclntyre K, Stern A, Presky D, Bradshaw D, Lad N, Gubler U. Studies on the IL-12R, and IL-12R antagonists: evidence that IL-12 is a critical mediator of both normal and pathologic Th1 dependent immune responses. Pathogenesis and immunotherapy of autoimmune diseases. Second Symposium, 25–27 October. Roche Milan 1996; 47
- Trincheri G. Control of production of interleukin-12 and its alteration in disease Pathogenesis and immunotherapy of autoimmune diseases. Second Symposium, 25–27 October. Roche Milan 1996; 48